Regulatory Challenges for Cartilage Repair Technologies

In the United States, few Food and Drug Administration (FDA)–approved options exist for the treatment of focal cartilage and osteochondral lesions. Developers of products for cartilage repair face many challenges to obtain marketing approval from the FDA. The objective of this review is to discuss t...

Descripción completa

Detalles Bibliográficos
Autores principales: McGowan, Kevin B., Stiegman, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297111/
https://www.ncbi.nlm.nih.gov/pubmed/26069647
http://dx.doi.org/10.1177/1947603512460756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297111/
https://www.ncbi.nlm.nih.gov/pubmed/26069647
http://dx.doi.org/10.1177/1947603512460756

Ejemplares similares